Recovered from Covid 19. We are up & running. We are accepting orders now!

Home » Tricalcium Phosphate Nanoparticles {Ca3(PO4)2, Purity: 99.9%, APS: <80nm}

NANOPOWDER COMPOUNDS

Stock No. CAS MSDS Specification COA Catalogue
NS6130-02-257 7758-87-4 MSDS pdf Specification pdf COA pdf

Tricalcium Phosphate Nanoparticles

{Ca3(PO4)2, Purity: 99.9%, APS: <80nm}

Moira-100®

Available Pack Size: 10Gms, 25Gms, 50Gms, 100Gms, 250Gms, 500Gms, 1Kg & Bulk orders
SEM - Tri Calcium Phosphate

SEM - Tri Calcium Phosphate

Particles Size Analysis

Particles Size Analysis

Tri Calcium Phosphate

Tri Calcium Phosphate

 
Product Tricalcium Phosphate Nanoparticles
Stock No. NS6130-02-257
CAS 7758-87-4 Confirm
APS <80nm Confirm
Purity 99.9 % Confirm
Molecular Formula Ca3(PO4)2 Confirm
Molecular Weight 310.18 g/mol Confirm
Form Powder Confirm
Color White shapeless powder Confirm
Density 3.18 g/cm³ Confirm
Melting Point >450 °C Confirm
Solubility Soluble in water Confirm
Quality Control Each lot of Tricalcium Phosphate Nanoparticles was tested successfully.
Main Inspect Verifier Manager QC

Typical Chemical Analysis

Assay 99.9%
Other Metal 900ppm

Expert Reviews

Dr. Myron Rubenstein, Ph.D (Polytechnic University of Turin, Italy)

Tricalcium phosphate nanoparticles are of interest to many biomedical applications because of their good biocompatibility and bioactivity. Hydroxyapatite (HA) has been utilized as implant coatings and bone substitutes. Amorphous calcium phosphate (ACP) are employed as remineralization agents both in-situ and in tooth restorative materials. It is utilized either as components or formed as products of calcium phosphate bone cement.

 


Dr. Huojin Chan,  (University of Science and Technology of China, Hefei, Anhui, China)

Tricalcium phosphate-based ceramics found to be attractive materials for orthopedic applications. Tricalcium phosphate nanoparticles due to their bioactivity and biocompatibility. It can also be used for encapsulating antibiotics. Calcium Phosphate Nanoparticles cause very little inflammation to human muscles as compare to other nanoparticles utilized in the drug delivery system.


Dr. Ms. Yi Yen Shi,  (King Mongkut’s University of Technology Thonburi,Bangkok, Thailand)

Tricalcium phosphate nanoparticles, they will be protected from the outer environment and prevented from undesired release to normal tissues or cells during circulation; after accumulating in solid tumor tissue and internalizing into tumor cells, these agents are finally released in endosomes or lysosomes. Therefore, calcium phosphate nanoparticles (CPNPs) have been supposed one of the most promising delivery devices for cancer diagnosis or therapy.


Dr. Bruce Perrault, Ph.D (Georgia Institute of Technology (Georgia Tech), USA)

Tricalcium phosphate nanostructures (AMCPs), which trap macromolecules, for instance, antigens and bacterial peptidoglycan, and transport them to the immune cells of the intestinal tissue. Tricalcium phosphate nanoparticles as carriers of therapeutic and imaging agents have recently raised great interest in nanomedicine. CaPs nanoparticles, as well as other kinds of nanoparticles, can be engineered to specifically target the site of the disease (cells or organs), thus minimizing their dispersion in the body and undesired organism-nanoparticles interactions. The most promising and efficient approach to improve their specificity is the “active targeting”, where nanoparticles are conjugated with a targeting moiety able to recognize and bind with high efficacy and selectivity to receptors that are highly expressed only in the therapeutic site.


Tricalcium Phosphate Nanoparticles

Tricalcium Phosphate Nanoparticles


Note
*Exchanges of materials/products are not permitted. Nanoshel does not offer refunds.
*US Dollar Cheques Not Accepted, Only Bank TT/Credit Cards Accepted